Roberto Rabinovich
- Does oxidative stress modulate limb muscle atrophy in severe COPD patients?By Clara Fermoselle, Roberto Rabinovich, Pilar Ausín, Ester Puig-Vilanova, Carlos Coronell, Francisco Sanchez, Josep Roca, Joaquim Gea and Esther BarreiroClara Fermoselle*Pulmonology Dept, Muscle and Respiratory System Research Unit, IMIM-Hospital del Mar, Health and Experimental Sciences Dept, Universitat Pompeu Fabra, PRBB, Barcelona#Centro de Investigación en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Bunyola, Majorca, SpainRoberto Rabinovich#Centro de Investigación en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Bunyola, Majorca, Spain¶Servei de Pneumologia (ICT), Hospital Clinic, IDIBAPS, Universitat de Barcelona, BarcelonaPilar Ausín*Pulmonology Dept, Muscle and Respiratory System Research Unit, IMIM-Hospital del Mar, Health and Experimental Sciences Dept, Universitat Pompeu Fabra, PRBB, BarcelonaEster Puig-Vilanova*Pulmonology Dept, Muscle and Respiratory System Research Unit, IMIM-Hospital del Mar, Health and Experimental Sciences Dept, Universitat Pompeu Fabra, PRBB, Barcelona#Centro de Investigación en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Bunyola, Majorca, SpainCarlos Coronell*Pulmonology Dept, Muscle and Respiratory System Research Unit, IMIM-Hospital del Mar, Health and Experimental Sciences Dept, Universitat Pompeu Fabra, PRBB, BarcelonaFrancisco Sanchez*Pulmonology Dept, Muscle and Respiratory System Research Unit, IMIM-Hospital del Mar, Health and Experimental Sciences Dept, Universitat Pompeu Fabra, PRBB, Barcelona#Centro de Investigación en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Bunyola, Majorca, SpainJosep Roca#Centro de Investigación en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Bunyola, Majorca, Spain¶Servei de Pneumologia (ICT), Hospital Clinic, IDIBAPS, Universitat de Barcelona, BarcelonaJoaquim Gea*Pulmonology Dept, Muscle and Respiratory System Research Unit, IMIM-Hospital del Mar, Health and Experimental Sciences Dept, Universitat Pompeu Fabra, PRBB, Barcelona#Centro de Investigación en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Bunyola, Majorca, SpainEsther Barreiro*Pulmonology Dept, Muscle and Respiratory System Research Unit, IMIM-Hospital del Mar, Health and Experimental Sciences Dept, Universitat Pompeu Fabra, PRBB, Barcelona#Centro de Investigación en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Bunyola, Majorca, Spain
- Activity outcomes correlation of 6 monitors in COPD, a field study part of the PROactive projectBy Santiago Giavedoni, Roberto Rabinovich, Yogini Raste, Nicholas Hopkinson, Hans Van Remoortel, Eloisa M. Gatti Regueiro, Daniel Langer, Zafiris Louvaris, Ioannis Vogiatzis, Barry Peterson, Frederick Wilson and Thierry TroostersSantiago Giavedoni1Respiratory Medicine, ELEGI Colt Laboratories, CIR, The University of Edinburgh, Edinburgh, United KingdomRoberto Rabinovich1Respiratory Medicine, ELEGI Colt Laboratories, CIR, The University of Edinburgh, Edinburgh, United KingdomYogini Raste2Respiratory Muscle Laboratory, Royal Brompton Hospital, London, United KingdomNicholas Hopkinson2Respiratory Muscle Laboratory, Royal Brompton Hospital, London, United KingdomHans Van Remoortel3Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumEloisa M. Gatti RegueiroDaniel Langer3Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumZafiris Louvaris5Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceIoannis Vogiatzis5Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceBarry Peterson6Pfizer Global Research and Development, Pfizer, Sandwich, Kent, United KingdomFrederick Wilson6Pfizer Global Research and Development, Pfizer, Sandwich, Kent, United KingdomThierry Troosters3Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
- Activity monitor outcomes in COPD – Assessment of variability of 6 monitors as part of the IMI PROactive projectBy Zafeiris Louvaris, Daniel Langer, Santiago Giavedoni, Yogini Raste, Hans Van Remoortel, Eloisa Maria Gatti Regueiro, Frederick Wilson, Ioannis Vogiatzis, Nicholas Hopkinson, Roberto Rabinovich, Barry Peterson and Thierry TroostersZafeiris LouvarisDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomDaniel LangerDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomSantiago GiavedoniDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomYogini RasteDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomHans Van RemoortelDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomEloisa Maria Gatti RegueiroDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomFrederick WilsonDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomIoannis VogiatzisDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomNicholas HopkinsonDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomRoberto RabinovichDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomBarry PetersonDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomThierry TroostersDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
- Validity of 6 activity monitors during standard physical activities in COPD – Comparison with indirect calorimetryBy Yogini Raste, Daniel Langer, Chris Burtin, Zafiris Louvaris, Santiago Giavedoni, Francesco Costa, Frederick Wilson, Roberto Rabinovich, Nicholas Hopkinson, Ioannis Vogiatzis, Barry Peterson and Thierry TroostersYogini Raste1Respiratory Medicine, NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, United KingdomDaniel Langer2Faculty of Kinesiology and Rehabilitation Science, KU Leuven, Leuven, BelgiumChris Burtin2Faculty of Kinesiology and Rehabilitation Science, KU Leuven, Leuven, BelgiumZafiris Louvaris3Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceSantiago Giavedoni4ELEGI Colt Laboratories, Centre for Inflammation Research, University of Edinburgh, Edinburgh, United KingdomFrancesco Costa5Section of Pneumology, University of Pisa, Pisa, ItalyFrederick Wilson6Molecular Medicine, Physiological Measurements, Pfizer Worldwide Research and Development, Sandwich, Kent, United KingdomRoberto Rabinovich4ELEGI Colt Laboratories, Centre for Inflammation Research, University of Edinburgh, Edinburgh, United KingdomNicholas Hopkinson1Respiratory Medicine, NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, United KingdomIoannis Vogiatzis3Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceBarry Peterson7Molecular Medicine, Physiological Measurements, Pfizer Worldwide Research and Development, Groton, CT, United StatesThierry Troosters2Faculty of Kinesiology and Rehabilitation Science, KU Leuven, Leuven, Belgium
- Validity of activity monitors for physical activity assessment in patients with chronic obstructive pulmonary diseaseBy Roberto Rabinovich, Zafeiris Louvaris, Yogini Raste, Daniel Langer, Hans Van Remoortel, Santiago Giavedoni, Chris Burtin, Eloisa Regueiro, Ioannis Vogiatzis, Nicholas Hopkinson, Michael Polkey, Frederik Wilson, William MacNee, Klass Westerterp and Thierry TroostersRoberto Rabinovich1ELEGI Colt Laboratory, Centre for Inflammation Research, the Queen's Medical Research Institute, The University of Edinburgh, Scotland, United KingdomZafeiris Louvaris2Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian, University of Athens, GreeceYogini Raste3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomDaniel Langer4Faculty of Kinesiology and Rehabilitation Sciences, Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, BelgiumHans Van Remoortel4Faculty of Kinesiology and Rehabilitation Sciences, Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, BelgiumSantiago Giavedoni1ELEGI Colt Laboratory, Centre for Inflammation Research, the Queen's Medical Research Institute, The University of Edinburgh, Scotland, United KingdomChris Burtin4Faculty of Kinesiology and Rehabilitation Sciences, Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, BelgiumEloisa Regueiro5UFSCar, São Carlos, Universidade Federal de São Carlos, BrazilIoannis Vogiatzis2Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian, University of Athens, GreeceNicholas Hopkinson3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomMichael Polkey3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomFrederik Wilson6Precision Medicine, Pfizer Worldwide Research and Development, Pfizer, Kent, United KingdomWilliam MacNee1ELEGI Colt Laboratory, Centre for Inflammation Research, the Queen's Medical Research Institute, The University of Edinburgh, Scotland, United KingdomKlass Westerterp7Department of Human Biology, Maastricht University, Maastricht, NetherlandsThierry Troosters4Faculty of Kinesiology and Rehabilitation Sciences, Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, Belgium
- Video game exercise effectiveness of a domiciliary respiratory rehabilitation program in cystic fibrosis (CF) patientsBy Tamara del Corral, Roberto Martinez, Roberto Rabinovich and Vilaró JordiTamara del Corral1Respiratory Physiotherapy, Asociación Madrileña Contra la Fibrosis Quística (AMCFQ), Universidad Europea de Madrid, SpainRoberto Martinez1Respiratory Physiotherapy, Asociación Madrileña Contra la Fibrosis Quística (AMCFQ), Universidad Europea de Madrid, SpainRoberto Rabinovich1Respiratory Physiotherapy, Asociación Madrileña Contra la Fibrosis Quística (AMCFQ), Universidad Europea de Madrid, SpainVilaró Jordi1Respiratory Physiotherapy, Asociación Madrileña Contra la Fibrosis Quística (AMCFQ), Universidad Europea de Madrid, Spain
- Autonomic cardiac dysfunction in COPD: The role of 6MWTBy Diego A. Rodriguez, Ane Arbillaga, Eleni Kortianou, Jennifer Alison, Alejandro Casas, Santiago Giavedoni, Anael Barberán, Jordi Vilaró, Ioannis Vogiatzis, Roberto Rabinovich, Elena Gimeno and Josep RocaDiego A. Rodriguez1Respiratory Medicine, Hospital Clínic i Provincial de Barcelona (ICT), CIBERES, IDIBAPS; Universidad de Barcelona, Hospital Clínic i Provincial de Barcelona (ICT), CIBERES, IDIBAPS; Universidad de Barcelona, Spain2Respiratory Medicine, Hopspital del Mar, CIBERES, UPF., Barcelona, SpainAne Arbillaga3Center for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainEleni Kortianou4Physiotherapy, Technological Educational Institution of Lamia Medicine, Pulmonary Rehabilitation Unit, Sotiria Hospital, Education and Sports Sciences, National and Kapodistrian, University of Athens, GreeceJennifer Alison5Discipline of Physiotherapy, Faculty of Health Sciences, The University of Sydney, AustraliaAlejandro Casas6Respiratory Medicine, Fundación Neumológica Colombiana, Bogotá, ColombiaSantiago Giavedoni7ELEGI/Colt Laboratory, UoE/MRCCentre for Inflammation Research, The Queen's Medical Research Institute, Edinburgh, United KingdomAnael Barberán2Respiratory Medicine, Hopspital del Mar, CIBERES, UPF., Barcelona, SpainJordi Vilaró8FCS Blanquerna, Grup de Recerca en Fisioterapia (GReF), Universitat Ramon Llull, Barcelona, SpainIoannis Vogiatzis4Physiotherapy, Technological Educational Institution of Lamia Medicine, Pulmonary Rehabilitation Unit, Sotiria Hospital, Education and Sports Sciences, National and Kapodistrian, University of Athens, GreeceRoberto Rabinovich7ELEGI/Colt Laboratory, UoE/MRCCentre for Inflammation Research, The Queen's Medical Research Institute, Edinburgh, United KingdomElena Gimeno3Center for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainJosep Roca2Respiratory Medicine, Hopspital del Mar, CIBERES, UPF., Barcelona, Spain
- Reduced mitochondrial density in the vastus lateralis muscle of COPD patients with low fat free massBy Santiago Giavedoni, Ellen Drost, Ramzi Lakhdar, William MacNee and Roberto RabinovichSantiago Giavedoni1ELEGI Colt Laboratory, Centre for Inflammation Research, the Queen's Medical Research Institute, The University of Edinburgh, Scotland, United KingdomEllen Drost1ELEGI Colt Laboratory, Centre for Inflammation Research, the Queen's Medical Research Institute, The University of Edinburgh, Scotland, United KingdomRamzi Lakhdar1ELEGI Colt Laboratory, Centre for Inflammation Research, the Queen's Medical Research Institute, The University of Edinburgh, Scotland, United KingdomWilliam MacNee1ELEGI Colt Laboratory, Centre for Inflammation Research, the Queen's Medical Research Institute, The University of Edinburgh, Scotland, United KingdomRoberto Rabinovich1ELEGI Colt Laboratory, Centre for Inflammation Research, the Queen's Medical Research Institute, The University of Edinburgh, Scotland, United Kingdom
- Heart rate recovery after 6-min walk test predicts acute exacerbation in COPDBy Diego A. Rodriguez, Ane Arbillaga, Eleni Kortianou, Jennifer Alison, Alejandro Casas, Santiago Giavedoni, Anael Barberan-Garcia, Jordi Vilaro, Elena Gimeno-Santos, Ioannis Vogiatzis, Roberto Rabinovich and Josep RocaDiego A. Rodriguez1Respiratory Medicine, Hospital De Mar-IMIM. Parc De Salut Mar. Dept CEXS, UPF. CIBERES (ISCiii), Barcelona, SpainAne Arbillaga2Center for Research in Environmental Epidemiology, (CREAL), CREAL, Barcelona, SpainEleni Kortianou3Physiotherapy, Technological Educational Institution of Lamia Medicine, Pulmonary Rehabilitation Unit, Sotiria Hospital, Education and Sports Sciences, National and Kapodistrian, University of Athens, Athens, GreeceJennifer Alison4Discipline of Physiotherapy, Faculty of Health Sciences, University of Sydney, Sydney, AustraliaAlejandro Casas5Respiratory Medicine, Fundación Neumológica Colombiana, Bogotá, ColombiaSantiago Giavedoni6ELEGI/Colt Laboratory, UoE/MRCCentre for Inflammation Research, The Queen's Medical Research Institute, Edimburg, United KingdomAnael Barberan-Garcia7Respiratory Medicine, Hospital Clínic I Provincial De Barcelona (ICT), CIBERES, IDIBAPS; Universidad De Barcelona, Barcelona, SpainJordi Vilaro8FCS Blanquerna, Grup De Recerca En Fisioterapia (GReF), Universitat Ramon Llull, Barcelona, SpainElena Gimeno-Santos2Center for Research in Environmental Epidemiology, (CREAL), CREAL, Barcelona, SpainIoannis Vogiatzis3Physiotherapy, Technological Educational Institution of Lamia Medicine, Pulmonary Rehabilitation Unit, Sotiria Hospital, Education and Sports Sciences, National and Kapodistrian, University of Athens, Athens, GreeceRoberto Rabinovich6ELEGI/Colt Laboratory, UoE/MRCCentre for Inflammation Research, The Queen's Medical Research Institute, Edimburg, United KingdomJosep Roca7Respiratory Medicine, Hospital Clínic I Provincial De Barcelona (ICT), CIBERES, IDIBAPS; Universidad De Barcelona, Barcelona, Spain
- Agreement of classification of COPD patients' physical activity with two activity monitorsBy Heleen Demeyer, Roberto Rabinovich, Susan Loh, Yogini Raste, Nick Hopkinson, Zafiris Louvaris, Iannis Vogiatzis, Corina De Jong, Tys Van der Molen, Elena Gimeno-Santos, Solange Rohou, Damijan Erzen, Karoly Kulich, Niklas Karlsson, Thierry Troosters and Judith Garcia AymerichHeleen Demeyer1Department of Rehabilitation Sciences, KULeuven, Leuven, BelgiumRoberto Rabinovich2ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, Scotland, United KingdomSusan Loh2ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, Scotland, United KingdomYogini Raste3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomNick Hopkinson3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomZafiris Louvaris4Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceIannis Vogiatzis4Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceCorina De Jong5Department of General Practice, University Medical Center Groningen, Groningen, NetherlandsTys Van der Molen6Department of Primary Care, University of Groningen, UMCG, Groningen, NetherlandsElena Gimeno-Santos7Centre for Research in Environmental Epidemiology, CREAL, Barcelona, SpainSolange Rohou8R&D, Astra Zeneca, Mölndal, SwedenDamijan Erzen10Respiratory Diseases Research, Boehringer-Ingelheim, Ingelheim, GermanyKaroly Kulich9Respiratory, Novartis, Basel, SwitzerlandNiklas Karlsson8R&D, Astra Zeneca, Mölndal, SwedenThierry Troosters1Department of Rehabilitation Sciences, KULeuven, Leuven, BelgiumJudith Garcia Aymerich7Centre for Research in Environmental Epidemiology, CREAL, Barcelona, Spain
- Patient reported outcomes for the measurement of physical activity in COPD patients. The PROactive toolsBy Elena Gimeno-Santos, Yogini Raste, Zafiris Louvaris, Corina de Jong, Heleen Demeyer, Roberto Rabinovich, Nicholas Hopkinson, Iannis Vogiatzis, Karoly Kulich, Damijan Erzen, Maggie Tabberer, Milo Puhan, Nathalie Ivanoff, Xavier Basagaña, Ignasi Serra, Pim de Boer, Fabienne Dobbels, Thys van der Molen, Michael Polkey, Thierry Troosters, Niklas Karlsson and Judith Garcia-AymerichElena Gimeno-Santos1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainYogini Raste2NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield, NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomZafiris Louvaris3Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceCorina de Jong4Department of General Practice, University Medical Center Groningen, Groningen, NetherlandsHeleen Demeyer5Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumRoberto Rabinovich6ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, the University of Edinburgh, Edinburgh, United KingdomNicholas Hopkinson2NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield, NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomIannis Vogiatzis3Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceKaroly Kulich7Respiratory Department, Novartis, Basel, SwitzerlandDamijan Erzen8Boehringer Ingelheim Pharma GmbH & Co., KG Clinical Research - Respiratory, Ingelheim am Rhein, GermanyMaggie Tabberer9Global Health Outcomes, GlaxoSmithKline, Brentford, United KingdomMilo Puhan10Horten Centre for Patient-Oriented Research, University Hospital of Zurich, Zurich, SwitzerlandNathalie Ivanoff11Respiratory Department, Almirall, Sant Feliu de Llobregat, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainIgnasi Serra1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainPim de Boer12Lung, Netherlands Asthma Foundation, Amersfoort, NetherlandsFabienne Dobbels13Center for Health Services and Nursing Research, Katholieke Universiteit Leuven, Leuven, BelgiumThys van der Molen14Department of Primary Care, University of Groningen, UMCG, Groningen, NetherlandsMichael Polkey2NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield, NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomThierry Troosters5Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumNiklas Karlsson15R&D, Astra Zeneca, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, Spain
- Does oxidative stress modulate limb muscle atrophy in severe copd patients?By Clara Fermoselle, Roberto Rabinovich, Pilar Ausín, Ester Puig-Vilanova, Carlos Coronell, Francisco Sanchez, Josep Roca, Joaquim Gea and Esther BarreiroArticle | Published in 2012 in European Respiratory JournalClara FermoselleRoberto RabinovichPilar AusínEster Puig-VilanovaCarlos CoronellFrancisco SanchezJosep RocaJoaquim GeaEsther Barreiro
- The PROactive innovative conceptual framework on physical activityBy Fabienne Dobbels, Corina de Jong, Ellen Drost, Janneke Elberse, Chryssoula Feridou, Laura Jacobs, Roberto Rabinovich, Anja Frei, Milo A. Puhan, Willem I. de Boer, Thys van der Molen, Kate Williams, Hillary Pinnock, Thierry Troosters, Niklas Karlsson, Karoly Kulich, Katja Rüdell and the PROactive consortiumArticle | Published in 2014 in European Respiratory JournalFabienne Dobbels1Health Services and Nursing Research, University of Leuven, Leuven, BelgiumCorina de Jong2Dept of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands13These authors equally contributedEllen Drost3ELEGI Laboratory, Center for Inflammation Research, University of Edinburgh, Edinburgh, UK13These authors equally contributedJanneke Elberse4Lung Foundation Netherlands, Amersfoort, The Netherlands13These authors equally contributedChryssoula Feridou5Dept of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, Greece13These authors equally contributedLaura Jacobs1Health Services and Nursing Research, University of Leuven, Leuven, Belgium13These authors equally contributedRoberto Rabinovich3ELEGI Laboratory, Center for Inflammation Research, University of Edinburgh, Edinburgh, UKAnja Frei6Horten Centre and Institute of Social and Preventive Medicine, University of Zurich, Zurich, SwitzerlandMilo A. Puhan6Horten Centre and Institute of Social and Preventive Medicine, University of Zurich, Zurich, SwitzerlandWillem I. de Boer4Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen2Dept of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKate Williams7Outcomes and Evidence, Global Health and Value, Pfizer, Walton Oaks, UKHillary Pinnock8Allergy and Respiratory Research Group, Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UKThierry Troosters9Dept of Rehabilitation Sciences, University of Leuven, Leuven, BelgiumNiklas Karlsson10AstraZeneca, Research and Development, Health Economics and Outcomes Research, Medical Science, Mölndal, SwedenKaroly Kulich11Patient Reported Outcomes Division, Novartis, Basel, SwitzerlandKatja Rüdell7Outcomes and Evidence, Global Health and Value, Pfizer, Walton Oaks, UK12For a list of the PROactive consortium members see the Acknowledgements section
- The PROactive innovative conceptual framework on physical activityBy Fabienne Dobbels, Corina de Jong, Ellen Drost, Janneke Elberse, Chryssoula Feridou, Laura Jacobs, Roberto Rabinovich, Anja Frei, Milo A. Puhan, Willem I. de Boer, Thys van der Molen, Kate Williams, Hillary Pinnock, Thierry Troosters, Niklas Karlsson, Karoly Kulich, Katja Rüdell and the PROactive consortiumFabienne Dobbels1Health Services and Nursing Research, University of Leuven, Leuven, BelgiumCorina de Jong2Dept of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands13These authors equally contributedEllen Drost3ELEGI Laboratory, Center for Inflammation Research, University of Edinburgh, Edinburgh, UK13These authors equally contributedJanneke Elberse4Lung Foundation Netherlands, Amersfoort, The Netherlands13These authors equally contributedChryssoula Feridou5Dept of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, Greece13These authors equally contributedLaura Jacobs1Health Services and Nursing Research, University of Leuven, Leuven, Belgium13These authors equally contributedRoberto Rabinovich3ELEGI Laboratory, Center for Inflammation Research, University of Edinburgh, Edinburgh, UKAnja Frei6Horten Centre and Institute of Social and Preventive Medicine, University of Zurich, Zurich, SwitzerlandMilo A. Puhan6Horten Centre and Institute of Social and Preventive Medicine, University of Zurich, Zurich, SwitzerlandWillem I. de Boer4Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen2Dept of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKate Williams7Outcomes and Evidence, Global Health and Value, Pfizer, Walton Oaks, UKHillary Pinnock8Allergy and Respiratory Research Group, Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UKThierry Troosters9Dept of Rehabilitation Sciences, University of Leuven, Leuven, BelgiumNiklas Karlsson10AstraZeneca, Research and Development, Health Economics and Outcomes Research, Medical Science, Mölndal, SwedenKaroly Kulich11Patient Reported Outcomes Division, Novartis, Basel, SwitzerlandKatja Rüdell7Outcomes and Evidence, Global Health and Value, Pfizer, Walton Oaks, UK12For a list of the PROactive consortium members see the Acknowledgements section
- 18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging:comparative methodology in COPD patientsBy Gourab Choudhury, Alison Fletcher, Martin Connell, Tim Clark, Susie Ferguson, Roberto Rabinovich, Nick Weir, Brandon Whitcher, Iain Kilty, William Vennart, Edwin J.R. van Beek and William MacNeeGourab Choudhury1Centre for Research and Inflammation, Queens Medical Research Institute, Edinburgh, United KingdomAlison Fletcher2Clinical Research Imaging Centre, Queens Medical Research Institute, Edinburgh, United KingdomMartin Connell2Clinical Research Imaging Centre, Queens Medical Research Institute, Edinburgh, United KingdomTim Clark2Clinical Research Imaging Centre, Queens Medical Research Institute, Edinburgh, United KingdomSusie Ferguson1Centre for Research and Inflammation, Queens Medical Research Institute, Edinburgh, United KingdomRoberto Rabinovich1Centre for Research and Inflammation, Queens Medical Research Institute, Edinburgh, United KingdomNick Weir2Clinical Research Imaging Centre, Queens Medical Research Institute, Edinburgh, United KingdomBrandon Whitcher3Pfizer Worldwide Research & Development, Pfizer Worldwide Research & Development, Cambridge, MA,Iain Kilty3Pfizer Worldwide Research & Development, Pfizer Worldwide Research & Development, Cambridge, MA,William Vennart3Pfizer Worldwide Research & Development, Pfizer Worldwide Research & Development, Cambridge, MA,Edwin J.R. van Beek2Clinical Research Imaging Centre, Queens Medical Research Institute, Edinburgh, United KingdomWilliam MacNee1Centre for Research and Inflammation, Queens Medical Research Institute, Edinburgh, United Kingdom
- Circulating desmosine relates to cardiovascular comorbidity, coronary artery calcification score (CACS), systemic inflammation and mortality in patients with COPDBy Roberto Rabinovich, Bruce Millar, Karolina Wrobel, Gourag Chaudhury, Kareshma Ranjit, Ellen Drost, Lisa Edwards, David Lomas, Stephen Rennard, Alvar Agusti, Ruth Tal-Singer, Jørgen Vestbo, Emiel Wouters, Edwin J.R. Van Beek, John Murchison, William MacNee and Jeffrey HuangRoberto Rabinovich1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomBruce Millar3GlaxoSmithKline R&D, King of Prussia, GlsxoSmithKline, Pennsylvania,Karolina Wrobel2Medical Research Institute, School of Medicine, The University of Dundee, Dundee, Scotland, United KingdomGourag Chaudhury1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomKareshma Ranjit1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomEllen Drost1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomLisa Edwards4GlaxoSmithKline, Research Triangle Park, GlsxoSmithKline, NC,David Lomas5Faculty of Medical Sciences, University College London, London, United KingdomStephen Rennard6Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska, Omaha,Alvar Agusti7Hospital Clinic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias, FISIB, Universitat de Barclona, Barcelona, SpainRuth Tal-Singer3GlaxoSmithKline R&D, King of Prussia, GlsxoSmithKline, Pennsylvania,Jørgen Vestbo8Department of Respiratory Medicine, Odense University & University of Southern Denmark, Odense, DenmarkEmiel Wouters9Department of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, NetherlandsEdwin J.R. Van Beek10Clinical Research Imaging Centre, Queens Medical Research Institute, Edinburgh, United KingdomJohn Murchison11Department of Radiology, Royal Infirmary of Edinburgh, Edinburgh, United KingdomWilliam MacNee1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomJeffrey Huang2Medical Research Institute, School of Medicine, The University of Dundee, Dundee, Scotland, United Kingdom
- Longitudinal effects of anxiety and depression on physical activity in COPD patientsBy Iván Dueñas-Espín, Heleen Demeyer, Elena Gimeno-Santos, Mike Polkey, Roberto Rabinovich, Fabienne Dobbels, Niklas Karlsson, Thierry Troosters and Judith Garcia-AymerichIván Dueñas-Espín1Respiratory Program, Centre de Recerca en Epidemiologia Ambiental (CREAL), Barcelona, Spain2Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain3Secretaría Nacional de Ciencia, Educación Superior, Tecnología e Innovación del Ecuador, SENESCYT, Quito, EcuadorHeleen Demeyer4Health Services and Nursing Research, University of Leuven (KU Leuven), Leuven, BelgiumElena Gimeno-Santos1Respiratory Program, Centre de Recerca en Epidemiologia Ambiental (CREAL), Barcelona, SpainMike Polkey5Faculty of Medicine, National Heart & Lung Institute, Imperial College of London, London, United KingdomRoberto Rabinovich6Pneumology, The University of Edinburgh, Edinburgh, United KingdomFabienne Dobbels4Health Services and Nursing Research, University of Leuven (KU Leuven), Leuven, BelgiumNiklas Karlsson7AstraZeneca, AstraZeneca, R&D, Mölndal, SwedenThierry Troosters4Health Services and Nursing Research, University of Leuven (KU Leuven), Leuven, BelgiumJudith Garcia-Aymerich1Respiratory Program, Centre de Recerca en Epidemiologia Ambiental (CREAL), Barcelona, Spain2Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain
- Premature aging and skeletal muscle dysfunction in COPD patients: Development of a cell culture modelBy Lakhdar Ramzi, Choudhury Gourab, Jennifer McLeish, Elen Drost, Liane McGlynn, Paul Shiels, William MacNee and Roberto RabinovichLakhdar Ramzi1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomChoudhury Gourab1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomJennifer McLeish1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomElen Drost1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomLiane McGlynn2College of Medical, Veterinary & Life Sciences Institute of Cancer Sciences, The University of Glasgow, Glasgow, Scotland, United KingdomPaul Shiels2College of Medical, Veterinary & Life Sciences Institute of Cancer Sciences, The University of Glasgow, Glasgow, Scotland, United KingdomWilliam MacNee1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomRoberto Rabinovich1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United Kingdom
- Telomere attrition in circulating white blood cells in COPD relates to lung function and outcomesBy Roberto Rabinovich, Gourab Choudhuri, Ramzi Lakhdar, Ellen Drost, Liane McGlynn, Jing Bai, Paul Shiels, Bruce Millar, Ruth Tal-Singer, Alvar Agusti and William MacNeeRoberto Rabinovich1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomGourab Choudhuri1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomRamzi Lakhdar1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomEllen Drost1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomLiane McGlynn2College of Medical, Veterinary & Life Sciences Institute of Cancer Sciences, The University of Glasgow, Glasgow, Scotland, United KingdomJing Bai1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United KingdomPaul Shiels2College of Medical, Veterinary & Life Sciences Institute of Cancer Sciences, The University of Glasgow, Glasgow, Scotland, United KingdomBruce Millar3GlaxoSmithKline R&D, King of Prusia, GlsxoSmithKline, Pennsylvania,Ruth Tal-Singer3GlaxoSmithKline R&D, King of Prusia, GlsxoSmithKline, Pennsylvania,Alvar Agusti4Hospital Clinic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias, FISIB, Universitat de Barcelona, Barcelona, SpainWilliam MacNee1ELEGI/Colt Laboratory. Centre for Inflammation Research. The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, Scotland, United Kingdom
- Markers of ageing in the limb muscle of patients with COPDBy Ramzi Lakhdar, Ellen Drost, Paul G. Shiels, William MacNee and Roberto RabinovichRamzi Lakhdar1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens Medical Research Institute, Edinburgh, United KingdomEllen Drost1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens Medical Research Institute, Edinburgh, United KingdomPaul G. Shiels2University of Glasgow, College of Medical, Veterinary & Life Sciences Institute of Cancer Sciences, Glasgow, United KingdomWilliam MacNee1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens Medical Research Institute, Edinburgh, United KingdomRoberto Rabinovich1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens Medical Research Institute, Edinburgh, United Kingdom
- Validation of five non-invasive respiratory rate monitors in patients with COPD in a laboratory settingBy Noah Rubio, Richard Parker, Hilary Pinnock, Christopher Weir, Janet Hanley, Lucy McClougham, William MacNee, Brian McKinstry and Roberto RabinovichNoah Rubio1Edinburgh Lung and the Environment Group Initiative, University of Edinburgh, Edinburgh, United KingdomRichard Parker2Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United KingdomHilary Pinnock2Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United KingdomChristopher Weir2Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United KingdomJanet Hanley3School of Nursing (Midwifery and Social Care ), Edinburgh Napier University, Edinburgh, United KingdomLucy McClougham2Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United KingdomWilliam MacNee1Edinburgh Lung and the Environment Group Initiative, University of Edinburgh, Edinburgh, United KingdomBrian McKinstry2Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United KingdomRoberto Rabinovich1Edinburgh Lung and the Environment Group Initiative, University of Edinburgh, Edinburgh, United Kingdom
- Apoptosis in vastus lateralis muscle of patients with COPDBy Ramzi Lakhdar, Ellen Drost, William MacNee and Roberto RabinovichRamzi LakhdarEdinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens Medical Research Institute, Edinburgh, United KingdomEllen DrostEdinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens Medical Research Institute, Edinburgh, United KingdomWilliam MacNeeEdinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens Medical Research Institute, Edinburgh, United KingdomRoberto RabinovichEdinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens Medical Research Institute, Edinburgh, United Kingdom
- LATE-BREAKING ABSTRACT: Increasing physical activity in patients with COPD using a telecoaching program: A multicenter RCTBy Heleen Demeyer, Zafeiris Louvaris, Rebecca Tanner, Noah Rubio, Anja Frei, Corina de Jong, Elena Gimeno Santos, Maarten Spruyt, Matthias Loeckx, Sara Buttery, Claire Yerramasu, Gilbert Buesching, Alexandra Strassmann, Ignasi Serra, Roberto Rabinovich, Iannis Vogiatzis, Michael Polkey, Judith Garcia Aymerich and Thierry TroostersHeleen Demeyer1Department of Respiratory Diseases, KU Leuven, University Hospitals Leuven, Leuven, BelgiumZafeiris Louvaris2Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, Athens, GreeceRebecca Tanner3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomNoah Rubio4ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United KingdomAnja Frei8Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandCorina de Jong7Department of General Practice, University Medical Centre Groningen, Groningen, NetherlandsElena Gimeno Santos5Programme in Respiratory Research, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, SpainMaarten Spruyt1Department of Respiratory Diseases, KU Leuven, University Hospitals Leuven, Leuven, BelgiumMatthias Loeckx1Department of Respiratory Diseases, KU Leuven, University Hospitals Leuven, Leuven, BelgiumSara Buttery3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomClaire Yerramasu4ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United KingdomGilbert Buesching6Klinik Barmelweid, Klinik Barmelweid, Barmelweid, SwitzerlandAlexandra Strassmann8Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandIgnasi Serra5Programme in Respiratory Research, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, SpainRoberto Rabinovich4ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United KingdomIannis Vogiatzis2Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, Athens, GreeceMichael Polkey3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomJudith Garcia Aymerich5Programme in Respiratory Research, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, SpainThierry Troosters1Department of Respiratory Diseases, KU Leuven, University Hospitals Leuven, Leuven, Belgium
- Tele-coaching to promote physical activity in patients with COPD: Evaluation by patientsBy Heleen Demeyer, Zafeiris Louvaris, Anja Frei, Corina De Jong, Matthias Loeckx, Gilbert Buesching, Sara Buttery, Maarten Spruyt, Rebecca Tanner, Noah Rubio, Elena Gimeno-Santos, Nick Hopkinson, Roberto Rabinovich, Michael Polkey, Judith Garcia-Aymerich, Iannis Vogiatzis and Thierry TroostersHeleen Demeyer1Department of Respiratory Diseases, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, BelgiumZafeiris Louvaris2Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens; M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceAnja Frei3Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandCorina De Jong7Department of General Practice, University Medical Center Groningen, Groningen, NetherlandsMatthias Loeckx1Department of Respiratory Diseases, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, BelgiumGilbert Buesching8Klink Barmelweid, Klink Barmelweid, Barmelweid, SwitzerlandSara Buttery4NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomMaarten Spruyt1Department of Respiratory Diseases, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, BelgiumRebecca Tanner4NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomNoah Rubio5ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United KingdomElena Gimeno-Santos6Programme in Respiratory Research, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, SpainNick Hopkinson4NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomRoberto Rabinovich5ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United KingdomMichael Polkey4NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomJudith Garcia-Aymerich6Programme in Respiratory Research, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, SpainIannis Vogiatzis2Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens; M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceThierry Troosters1Department of Respiratory Diseases, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, Belgium
- Use of exercise testing in the evaluation of interventional efficacy: an official ERS statementBy Luis Puente-Maestu, Paolo Palange, Richard Casaburi, Pierantonio Laveneziana, François Maltais, J. Alberto Neder, Denis E. O'Donnell, Paolo Onorati, Janos Porszasz, Roberto Rabinovich, Harry B. Rossiter, Sally Singh, Thierry Troosters and Susan WardArticle | Published in 2016 in European Respiratory JournalLuis Puente-Maestu1Servicio de Neumología del Hospital Universitario Gregorio Marañón, Madrid, Spain2Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain3Facultad de Medicina de la Universidad Complutense de Madrid, Madrid, SpainPaolo Palange4Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Rome, ItalyRichard Casaburi5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USAPierantonio Laveneziana6UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Universités, UPMC Université Paris 06, INSERM, Paris, France7Service des Explorations Fonctionnelles de la Respiration, de l'Exercice et de la Dyspnée, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Paris, FranceFrançois Maltais8Institut Universitaire Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, CanadaJ. Alberto Neder9Laboratory of Clinical Exercise Physiology, Division of Respiratory and Critical Care Medicine, Queen's University and Kingston General Hospital, Kingston, ON, Canada10Division of Respirology, Clinical Exercise Physiology Unit, Federal University of Sao Paulo, Sao Paulo, BrazilDenis E. O'Donnell11Respiratory Investigation Unit, Division of Respiratory and Critical Care Medicine, Queen's University and Kingston General Hospital, Kingston, ON, CanadaPaolo Onorati4Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Rome, Italy12Ospedale Civile di Alghero, ASL1-Sassari, Alghero (SS), ItalyJanos Porszasz5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USARoberto Rabinovich13ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen`s Medical Research Institute, University of Edinburgh, Edinburgh, UKHarry B. Rossiter5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA14Faculty of Biological Sciences, University of Leeds, Leeds, UKSally Singh15Centre for Exercise and Rehabilitation Science, Glenfield Hospital, University Hospitals of Leciester NHS Trust, Leciester, UKThierry Troosters16Dept of Rehabilitation Sciences, KU Leuven, Leuven, Belgium17Respiratory Rehabilitation Division, University Hospital Gasthuisberg, Leuven, BelgiumSusan Ward18Human Bio-Energetics Research Centre, Crickhowell, UK
- Use of exercise testing in the evaluation of interventional efficacy: an official ERS statementBy Luis Puente-Maestu, Paolo Palange, Richard Casaburi, Pierantonio Laveneziana, François Maltais, J. Alberto Neder, Denis E. O'Donnell, Paolo Onorati, Janos Porszasz, Roberto Rabinovich, Harry B. Rossiter, Sally Singh, Thierry Troosters and Susan WardLuis Puente-Maestu1Servicio de Neumología del Hospital Universitario Gregorio Marañón, Madrid, Spain2Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain3Facultad de Medicina de la Universidad Complutense de Madrid, Madrid, SpainPaolo Palange4Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Rome, ItalyRichard Casaburi5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USAPierantonio Laveneziana6UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Universités, UPMC Université Paris 06, INSERM, Paris, France7Service des Explorations Fonctionnelles de la Respiration, de l'Exercice et de la Dyspnée, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Paris, FranceFrançois Maltais8Institut Universitaire Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, CanadaJ. Alberto Neder9Laboratory of Clinical Exercise Physiology, Division of Respiratory and Critical Care Medicine, Queen's University and Kingston General Hospital, Kingston, ON, Canada10Division of Respirology, Clinical Exercise Physiology Unit, Federal University of Sao Paulo, Sao Paulo, BrazilDenis E. O'Donnell11Respiratory Investigation Unit, Division of Respiratory and Critical Care Medicine, Queen's University and Kingston General Hospital, Kingston, ON, CanadaPaolo Onorati4Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Rome, Italy12Ospedale Civile di Alghero, ASL1-Sassari, Alghero (SS), ItalyJanos Porszasz5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USARoberto Rabinovich13ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen`s Medical Research Institute, University of Edinburgh, Edinburgh, UKHarry B. Rossiter5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA14Faculty of Biological Sciences, University of Leeds, Leeds, UKSally Singh15Centre for Exercise and Rehabilitation Science, Glenfield Hospital, University Hospitals of Leciester NHS Trust, Leciester, UKThierry Troosters16Dept of Rehabilitation Sciences, KU Leuven, Leuven, Belgium17Respiratory Rehabilitation Division, University Hospital Gasthuisberg, Leuven, BelgiumSusan Ward18Human Bio-Energetics Research Centre, Crickhowell, UK
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.